BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7855121)

  • 41. Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania.
    Nandan D; Zhang N; Yu Y; Schwartz B; Chen S; Kima PE; Reiner NE
    PLoS One; 2018; 13(11):e0206920. PubMed ID: 30399177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
    Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB
    Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening.
    Ashutosh ; Gupta S; Ramesh ; Sundar S; Goyal N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3776-83. PubMed ID: 16131481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
    J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
    Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
    J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
    Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
    J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.
    Neal RA; Croft SL
    J Antimicrob Chemother; 1984 Nov; 14(5):463-75. PubMed ID: 6096347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India.
    Singh SK; Bimal S; Narayan S; Jee C; Bimal D; Das P; Bimal R
    Exp Parasitol; 2011 Feb; 127(2):552-8. PubMed ID: 21070771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of combined immunostimulation and chemotherapy in experimental visceral Leishmaniasis.
    Haidaris CG; Bonventre PF
    Am J Trop Med Hyg; 1983 Mar; 32(2):286-95. PubMed ID: 6301300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol.
    Hendrickx S; Inocêncio da Luz RA; Bhandari V; Kuypers K; Shaw CD; Lonchamp J; Salotra P; Carter K; Sundar S; Rijal S; Dujardin JC; Cos P; Maes L
    PLoS Negl Trop Dis; 2012; 6(5):e1664. PubMed ID: 22666513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis.
    Chakrabarti G; Basu A; Manna PP; Mahato SB; Mandal NB; Bandyopadhyay S
    J Antimicrob Chemother; 1999 Mar; 43(3):359-66. PubMed ID: 10223591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
    Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
    Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diversity among Leishmania isolates from the Sudan: isoenzyme homogeneity of L. donovani versus heterogeneity of L. major.
    Ibrahim ME; Evans DA; Theander TG; el Hassan AM; Kharazmi A
    Trans R Soc Trop Med Hyg; 1995; 89(4):366-9. PubMed ID: 7570863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.
    Berman JD; Chulay JD; Hendricks LD; Oster CN
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):459-65. PubMed ID: 7081539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani.
    Wyllie S; Cunningham ML; Fairlamb AH
    J Biol Chem; 2004 Sep; 279(38):39925-32. PubMed ID: 15252045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain.
    Samarasinghe SR; Samaranayake N; Kariyawasam UL; Siriwardana YD; Imamura H; Karunaweera ND
    BMC Genomics; 2018 Nov; 19(1):843. PubMed ID: 30486770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.